Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 24. November 2020
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1975  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 39495  
   
Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts.
J Natl Cancer Inst
Hu Y, Zhang X, Ma Y, Yuan C, Wang M, Wu K, Tabung FK, Tobias D, Hu FB, Giovannucci E, Song M.
PMID: 33225344 [PubMed - as supplied by publisher]


Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolomic study.
Gland Surg
Wei B, Wang C, Teng T, Guo P, Chen M, Xia F, Liu H, Xie J, Feng J, Huang H.
PMID: 33224818 [PubMed]


In vivo bioluminescence tomography-guided radiation research platform for pancreatic cancer: an initial study using subcutaneous and orthotopic pancreatic tumor models.
Proc SPIE Int Soc Opt Eng
Deng Z, Xu X, Dehghani H, Reyes J, Zheng L, Klose AD, Wong JW, Tran PT, Wang KK.
PMID: 33223595 [PubMed]


Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts.
Nutr Metab Cardiovasc Dis
Ling S, Brown K, Miksza JK, Howells LM, Morrison A, Issa E, Yates T, Khunti K, Davies MJ, Zaccardi F.
PMID: 33223399 [PubMed - as supplied by publisher]


Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study.
Eur J Heart Fail
Anker MS, von Haehling S, Coats AJ, Riess H, Eucker J, Porthun J, Butler J, Karakas M, Haverkamp W, Landmesser U, Anker SD.
PMID: 33222388 [PubMed - as supplied by publisher]


Surgical Management of Genitourinary Cancer Liver Metastases.
Surg Oncol Clin N Am
Martel G, Bertens KA, Canil C.
PMID: 33220811 [PubMed - in process]


A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): long-term outcome.
Radiother Oncol
Teriaca MA, Loi M, Suker M, Eskens FALM, van Eijck CHJ, Nuyttens JJ.
PMID: 33217500 [PubMed - as supplied by publisher]


SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer.
Radiother Oncol
Holyoake DLP, Robinson M, Silva M, Grose D, McIntosh D, Sebag-Montefiore D, Radhakrishna G, Mukherjee S, Hawkins MA.
PMID: 33217498 [PubMed - as supplied by publisher]


The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
J Hematol Oncol
Fang Z, Xu J, Zhang B, Wang W, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S.
PMID: 33213510 [PubMed - in process]


The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer.
Viruses
Haller SD, Monaco ML, Essani K.
PMID: 33213031 [PubMed - in process]


Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and Meta-Analysis.
Cancers (Basel)
De Simoni O, Scarpa M, Tonello M, Pilati P, Tolin F, Spolverato Y, Gruppo M.
PMID: 33213022 [PubMed]


Comparison between B-mode ultrasonography and contrast-enhanced ultrasonography for the surveillance of early stage pancreatic cancer: a retrospective study.
J Gastrointest Oncol
Xu J, Zhang M, Cheng G.
PMID: 33209500 [PubMed]


Inhibition of pyruvate dehydrogenase kinase influence microbiota and metabolomic profile in pancreatic cancer xenograft mice.
BMC Res Notes
Adamberg K, Vilu R, Pazienza V.
PMID: 33208188 [PubMed - in process]


Differences and similarities between cancer and somatic stem cells: therapeutic implications.
Stem Cell Res Ther
Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH.
PMID: 33208173 [PubMed - in process]


Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?
J Gastrointest Surg
Maxwell JE, Katz MHG.
PMID: 33205307 [PubMed - as supplied by publisher]


Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
Ann Surg
van Dongen JC, Suker M, Versteijne E, Bonsing BA, Mieog JSD, de Vos-Geelen J, van der Harst E, Patijn GA, de Hingh IH, Festen S, Ten Tije AJ, Busch OR, Besselink MG, van Tienhoven G, Groot Koerkamp B, van Eijck CHJ, Dutch Pancreatic Cancer Group..
PMID: 33201120 [PubMed - as supplied by publisher]


Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk.
Cancer Med
Zhao L, Liu H, Luo S, Moorman PG, Walsh KM, Li W, Wei Q.
PMID: 33200553 [PubMed - as supplied by publisher]


Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.
BMC Cancer
Ueno M, Ikeda M, Sasaki T, Nagashima F, Mizuno N, Shimizu S, Ikezawa H, Hayata N, Nakajima R, Morizane C.
PMID: 33198671 [PubMed - in process]


Pancreatic Fibroblast Heterogeneity: From Development to Cancer.
Cells
Garcia PE, Scales MK, Allen BL, Pasca di Magliano M.
PMID: 33198201 [PubMed - in process]


Immunomodulation in Pancreatic Cancer.
Cancers (Basel)
Krishnamoorthy M, Lenehan JG, Burton JP, Maleki Vareki S.
PMID: 33198059 [PubMed]


   
   Artikel 1 - 20 / 39495    Seite 1 von 1975  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1